[English] 日本語
Yorodumi
- PDB-9oio: The von Hippel Lindau-ElonginB-ElonginC (VCB) complex with fragme... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 9oio
TitleThe von Hippel Lindau-ElonginB-ElonginC (VCB) complex with fragments 9 and 14
Components
  • (von Hippel-Lindau disease tumor ...) x 2
  • Elongin-B
  • Elongin-C
KeywordsPROTEIN TRANSPORT / VHL / E3 ligase / Fragment-based drug discovery
Function / homology
Function and homology information


regulation of cellular response to hypoxia / RHOBTB3 ATPase cycle / negative regulation of receptor signaling pathway via JAK-STAT / transcription elongation factor activity / target-directed miRNA degradation / VCB complex / elongin complex / Replication of the SARS-CoV-1 genome / Cul5-RING ubiquitin ligase complex / intracellular membraneless organelle ...regulation of cellular response to hypoxia / RHOBTB3 ATPase cycle / negative regulation of receptor signaling pathway via JAK-STAT / transcription elongation factor activity / target-directed miRNA degradation / VCB complex / elongin complex / Replication of the SARS-CoV-1 genome / Cul5-RING ubiquitin ligase complex / intracellular membraneless organelle / Cul2-RING ubiquitin ligase complex / SUMOylation of ubiquitinylation proteins / negative regulation of transcription elongation by RNA polymerase II / Pausing and recovery of Tat-mediated HIV elongation / Tat-mediated HIV elongation arrest and recovery / HIV elongation arrest and recovery / Pausing and recovery of HIV elongation / Tat-mediated elongation of the HIV-1 transcript / ubiquitin-like ligase-substrate adaptor activity / Formation of HIV-1 elongation complex containing HIV-1 Tat / negative regulation of signal transduction / Formation of HIV elongation complex in the absence of HIV Tat / RNA Polymerase II Transcription Elongation / Formation of RNA Pol II elongation complex / negative regulation of TORC1 signaling / protein serine/threonine kinase binding / RNA Polymerase II Pre-transcription Events / negative regulation of autophagy / transcription corepressor binding / positive regulation of cell differentiation / transcription initiation at RNA polymerase II promoter / TP53 Regulates Transcription of DNA Repair Genes / transcription elongation by RNA polymerase II / Vif-mediated degradation of APOBEC3G / Inactivation of CSF3 (G-CSF) signaling / cell morphogenesis / Evasion by RSV of host interferon responses / Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha / Regulation of expression of SLITs and ROBOs / ubiquitin-protein transferase activity / transcription corepressor activity / Antigen processing: Ubiquitination & Proteasome degradation / positive regulation of proteasomal ubiquitin-dependent protein catabolic process / Neddylation / microtubule cytoskeleton / regulation of gene expression / Replication of the SARS-CoV-2 genome / protein-containing complex assembly / ubiquitin-dependent protein catabolic process / protein-macromolecule adaptor activity / DNA-binding transcription factor binding / cellular response to hypoxia / molecular adaptor activity / amyloid fibril formation / proteasome-mediated ubiquitin-dependent protein catabolic process / protein stabilization / protein ubiquitination / cilium / negative regulation of cell population proliferation / negative regulation of gene expression / ubiquitin protein ligase binding / regulation of DNA-templated transcription / regulation of transcription by RNA polymerase II / negative regulation of apoptotic process / positive regulation of DNA-templated transcription / enzyme binding / negative regulation of transcription by RNA polymerase II / endoplasmic reticulum / mitochondrion / proteolysis / nucleoplasm / nucleus / plasma membrane / cytosol
Similarity search - Function
von Hippel-Lindau disease tumour suppressor, beta/alpha domain / von Hippel-Lindau disease tumour suppressor, alpha domain / von Hippel-Lindau disease tumour suppressor, beta domain / VHL superfamily / von Hippel-Lindau disease tumour suppressor, alpha domain superfamily / von Hippel-Lindau disease tumour suppressor, beta domain superfamily / VHL beta domain / VHL box domain / Elongin-C / Elongin B ...von Hippel-Lindau disease tumour suppressor, beta/alpha domain / von Hippel-Lindau disease tumour suppressor, alpha domain / von Hippel-Lindau disease tumour suppressor, beta domain / VHL superfamily / von Hippel-Lindau disease tumour suppressor, alpha domain superfamily / von Hippel-Lindau disease tumour suppressor, beta domain superfamily / VHL beta domain / VHL box domain / Elongin-C / Elongin B / S-phase kinase-associated protein 1-like / SKP1 component, POZ domain / Skp1 family, tetramerisation domain / Found in Skp1 protein family / SKP1/BTB/POZ domain superfamily / Ubiquitin family / Ubiquitin homologues / Ubiquitin domain profile. / Ubiquitin-like domain / Ubiquitin-like domain superfamily
Similarity search - Domain/homology
: / : / von Hippel-Lindau disease tumor suppressor / Elongin-C / Elongin-B
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 2.3 Å
AuthorsAmporndanai, K. / Katinas, J.M. / Chopra, A. / Fesik, S.W.
Funding support United States, 1items
OrganizationGrant numberCountry
Other privateAWD00000788 United States
CitationJournal: Acs Med.Chem.Lett. / Year: 2025
Title: NMR-Based Fragment Screen of the von Hippel-Lindau Elongin C&B Complex
Authors: Amporndanai, K. / Katinas, J.M. / Chopra, A. / Kayode, O. / Vadukoot, A.K. / Waterson, A.G. / Fesik, S.W.
History
DepositionMay 6, 2025Deposition site: RCSB / Processing site: RCSB
Revision 1.0Jul 9, 2025Provider: repository / Type: Initial release

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Elongin-B
B: Elongin-C
C: von Hippel-Lindau disease tumor suppressor
D: Elongin-B
E: Elongin-C
F: von Hippel-Lindau disease tumor suppressor
G: Elongin-B
H: Elongin-C
I: von Hippel-Lindau disease tumor suppressor
J: Elongin-B
K: Elongin-C
L: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)176,14724
Polymers174,35012
Non-polymers1,79612
Water4,504250
1
A: Elongin-B
B: Elongin-C
C: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)43,9285
Polymers43,6143
Non-polymers3142
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
2
D: Elongin-B
E: Elongin-C
F: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)44,2127
Polymers43,6143
Non-polymers5994
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
3
G: Elongin-B
H: Elongin-C
I: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)43,8726
Polymers43,5103
Non-polymers3623
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
4
J: Elongin-B
K: Elongin-C
L: von Hippel-Lindau disease tumor suppressor
hetero molecules


Theoretical massNumber of molelcules
Total (without water)44,1346
Polymers43,6143
Non-polymers5213
Water543
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)92.904, 92.904, 359.384
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number91
Space group name H-MP4122
Space group name HallP4w2c
Symmetry operation#1: x,y,z
#2: -y,x,z+1/4
#3: y,-x,z+3/4
#4: x,-y,-z+1/2
#5: -x,y,-z
#6: -x,-y,z+1/2
#7: y,x,-z+3/4
#8: -y,-x,-z+1/4
Components on special symmetry positions
IDModelComponents
11G-202-

HOH

Noncrystallographic symmetry (NCS)NCS domain:
IDEns-IDDetails
d_1ens_1(chain "A" and ((resid 1 and (name N or name...
d_2ens_1(chain "D" and ((resid 1 and (name N or name...
d_3ens_1(chain "G" and (resid 1 through 8 or (resid 9...
d_4ens_1(chain "J" and ((resid 1 and (name N or name...
d_1ens_2(chain "B" and (resid 17 through 33 or (resid 34...
d_2ens_2(chain "E" and (resid 17 through 33 or (resid 34...
d_3ens_2(chain "H" and (resid 17 through 42 or (resid 43...
d_4ens_2(chain "K" and (resid 17 through 42 or (resid 43...
d_1ens_3(chain "C" and ((resid 62 and (name N or name...
d_2ens_3(chain "F" and (resid 62 through 76 or resid 78...
d_3ens_3(chain "I" and (resid 62 through 63 or (resid 64...
d_4ens_3(chain "L" and (resid 62 through 63 or (resid 64...

NCS domain segments:
Dom-IDComponent-IDEns-IDBeg auth comp-IDBeg label comp-IDEnd auth comp-IDEnd label comp-IDAuth asym-IDLabel asym-IDAuth seq-IDLabel seq-ID
d_11ens_1METMETPHEPHEAA1 - 791 - 79
d_12ens_1PHEPHEMETMETAA85 - 10385 - 103
d_21ens_1METMETMETMETDD1 - 1031 - 103
d_31ens_1METMETPHEPHEGG1 - 791 - 79
d_32ens_1PHEPHEMETMETGG85 - 10385 - 103
d_41ens_1METMETPHEPHEJJ1 - 791 - 79
d_42ens_1PHEPHEMETMETJJ85 - 10385 - 103
d_11ens_2METMETARGARGBB17 - 633 - 49
d_12ens_2ILEILETYRTYRBB65 - 8351 - 69
d_13ens_2ILEILECYSCYSBB90 - 11276 - 98
d_21ens_2METMETSERSEREE17 - 473 - 33
d_22ens_2ASNASNARGARGEE58 - 6344 - 49
d_23ens_2ILEILETYRTYREE65 - 8351 - 69
d_24ens_2ILEILECYSCYSEE90 - 11276 - 98
d_31ens_2METMETSERSERHH17 - 473 - 33
d_32ens_2ASNASNARGARGHH58 - 6344 - 49
d_33ens_2ILEILETYRTYRHH65 - 8351 - 69
d_34ens_2ILEILECYSCYSHH90 - 11276 - 98
d_41ens_2METMETSERSERKK17 - 473 - 33
d_42ens_2ASNASNARGARGKK58 - 6344 - 49
d_43ens_2ILEILECYSCYSKK65 - 11251 - 98
d_11ens_3VALVALPHEPHECC62 - 7629 - 43
d_12ens_3ASNASNPROPROCC78 - 17245 - 139
d_13ens_3ASNASNTHRTHRCC174 - 202141 - 169
d_14ens_3DMSDMSDMSDMSCN302
d_21ens_3VALVALPHEPHEFF62 - 7629 - 43
d_22ens_3ASNASNPROPROFF78 - 17245 - 139
d_23ens_3ASNASNTHRTHRFF174 - 202141 - 169
d_24ens_3DMSDMSDMSDMSFR303
d_31ens_3VALVALPHEPHEII62 - 7629 - 43
d_32ens_3ASNASNPROPROII78 - 17245 - 139
d_33ens_3ASNASNTHRTHRII174 - 202141 - 169
d_34ens_3DMSDMSDMSDMSIU301
d_41ens_3VALVALPHEPHELL62 - 7629 - 43
d_42ens_3ASNASNPROPROLL78 - 17245 - 139
d_43ens_3ASNASNTHRTHRLL174 - 202141 - 169
d_44ens_3DMSDMSDMSDMSLX302

NCS ensembles :
ID
ens_1
ens_2
ens_3

NCS oper:
IDCodeMatrixVector
1given(0.999271785861, -0.0380630098291, -0.00266557021779), (0.0380808669118, 0.999250116667, 0.00700370732957), (0.00239698917019, -0.00710011435557, 0.999971921015)46.633377991, 4.75867731843, -0.0946755201065
2given(0.993582137669, 0.0343313924017, -0.107777043942), (-0.03667530759, 0.999130251237, -0.0198409394169), (0.107002137914, 0.0236663592369, 0.99397708521)46.5594810034, -42.8760901497, 1.67329213961
3given(0.997059083984, 0.0221458058067, -0.0733672020009), (-0.0247297796221, 0.999098670017, -0.0345005154918), (0.0725370322257, 0.0362134071102, 0.996708065635)0.562436988994, -47.3000418904, 1.47205906139
4given(0.999516486965, -0.0303552908429, -0.00673413714757), (0.0303934456083, 0.999522112796, 0.00563777399423), (0.00655978272029, -0.00583972168813, 0.999961432707)46.4970046694, 4.68301886088, -0.0453189873024
5given(0.991004508577, 0.0199230331028, -0.132337208417), (-0.0250672608719, 0.998988898333, -0.0373204158526), (0.131459866165, 0.0403020316983, 0.990501918135)45.7204448926, -43.3677512288, 1.849607206
6given(0.995302801174, 0.0151543782417, -0.0956173561387), (-0.0200545421002, 0.998522864791, -0.0504965724592), (0.0947108722164, 0.0521769423126, 0.99413651848)-0.266673391305, -47.8075230181, 1.63513472788
7given(0.999640674346, 0.00473267662738, -0.0263841612435), (-0.0046298733263, 0.999981456482, 0.00395613003992), (0.0264023950725, -0.00383255317653, 0.999644049185)46.4139709275, 4.44551234088, 0.0260846030748
8given(0.996630256475, 0.0395380224099, -0.0718670763479), (-0.0422080526658, 0.998459300968, -0.0360208911811), (0.0703321560102, 0.0389328793597, 0.996763572135)46.9122566958, -43.36297162, 1.5317296173
9given(0.998248346536, 0.0333887562213, -0.0488408599124), (-0.0356799946536, 0.99826599902, -0.0468180860487), (0.0471929721517, 0.0484787186066, 0.997708693568)0.574393138334, -47.6709023532, 1.4636938422

-
Components

-
Protein , 2 types, 8 molecules ADGJBEHK

#1: Protein
Elongin-B / EloB / Elongin 18 kDa subunit / RNA polymerase II transcription factor SIII subunit B / SIII p18 / ...EloB / Elongin 18 kDa subunit / RNA polymerase II transcription factor SIII subunit B / SIII p18 / Transcription elongation factor B polypeptide 2


Mass: 11748.406 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: ELOB, TCEB2 / Production host: Escherichia coli (E. coli) / References: UniProt: Q15370
#2: Protein
Elongin-C / EloC / Elongin 15 kDa subunit / RNA polymerase II transcription factor SIII subunit C / SIII p15 / ...EloC / Elongin 15 kDa subunit / RNA polymerase II transcription factor SIII subunit C / SIII p15 / Transcription elongation factor B polypeptide 1


Mass: 11031.668 Da / Num. of mol.: 4
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: ELOC, TCEB1 / Production host: Escherichia coli (E. coli) / References: UniProt: Q15369

-
Von Hippel-Lindau disease tumor ... , 2 types, 4 molecules CFLI

#3: Protein von Hippel-Lindau disease tumor suppressor / Protein G7 / pVHL


Mass: 20833.514 Da / Num. of mol.: 3
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: VHL / Production host: Escherichia coli (E. coli) / References: UniProt: P40337
#4: Protein von Hippel-Lindau disease tumor suppressor / Protein G7 / pVHL


Mass: 20729.531 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: VHL / Production host: Escherichia coli (E. coli) / References: UniProt: P40337

-
Non-polymers , 4 types, 262 molecules

#5: Chemical ChemComp-A1CBL / 1-[(2-fluorophenyl)methyl]-4-(propan-2-yl)piperazine


Mass: 236.328 Da / Num. of mol.: 3 / Source method: obtained synthetically / Formula: C14H21FN2 / Feature type: SUBJECT OF INVESTIGATION
#6: Chemical
ChemComp-DMS / DIMETHYL SULFOXIDE


Mass: 78.133 Da / Num. of mol.: 6 / Source method: obtained synthetically / Formula: C2H6OS / Comment: DMSO, precipitant*YM
#7: Chemical ChemComp-A1CBK / 1-[6-[oxidanyl(oxidanylidene)-$l^{4}-azanyl]-2,3-dihydroindol-1-yl]ethanone


Mass: 206.198 Da / Num. of mol.: 3 / Source method: obtained synthetically / Formula: C10H10N2O3 / Feature type: SUBJECT OF INVESTIGATION
#8: Water ChemComp-HOH / water


Mass: 18.015 Da / Num. of mol.: 250 / Source method: isolated from a natural source / Formula: H2O

-
Details

Has ligand of interestY
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.22 Å3/Da / Density % sol: 44.69 %
Crystal growTemperature: 291 K / Method: vapor diffusion, hanging drop
Details: 0.1 M sodium cacodylate pH 5.5, 0.2 M magnesium acetate, 5 mM DTT and 14-20% PEG8000

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: ALS / Beamline: 8.2.2 / Wavelength: 1 Å
DetectorType: DECTRIS PILATUS 2M / Detector: PIXEL / Date: May 4, 2024
RadiationMonochromator: Si(111) / Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1 Å / Relative weight: 1
ReflectionResolution: 2.3→48.49 Å / Num. obs: 71258 / % possible obs: 99.88 % / Redundancy: 26.5 % / Biso Wilson estimate: 50.12 Å2 / CC1/2: 1 / Rmerge(I) obs: 0.1191 / Rpim(I) all: 0.0236 / Net I/σ(I): 19.12
Reflection shellResolution: 2.3→2.33 Å / Redundancy: 28 % / Rmerge(I) obs: 2.022 / Mean I/σ(I) obs: 2.03 / Num. unique obs: 2699 / CC1/2: 0.724 / Rpim(I) all: 0.387 / % possible all: 99.96

-
Processing

Software
NameVersionClassification
PHENIX1.21.1_5286refinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 2.3→48.49 Å / SU ML: 0.2763 / Cross valid method: FREE R-VALUE / σ(F): 1.34 / Phase error: 27.6225
Stereochemistry target values: GeoStd + Monomer Library + CDL v1.2
RfactorNum. reflection% reflection
Rfree0.2493 3591 5.05 %
Rwork0.2112 67584 -
obs0.2132 71175 99.88 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL
Displacement parametersBiso mean: 59.36 Å2
Refinement stepCycle: LAST / Resolution: 2.3→48.49 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms10381 0 120 250 10751
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.009110755
X-RAY DIFFRACTIONf_angle_d1.112114625
X-RAY DIFFRACTIONf_chiral_restr0.05981658
X-RAY DIFFRACTIONf_plane_restr0.01041912
X-RAY DIFFRACTIONf_dihedral_angle_d18.33634027
Refine LS restraints NCS
Ens-IDDom-IDAsym-IDAuth asym-IDRefine-IDTypeRms dev position (Å)
ens_1d_2AAX-RAY DIFFRACTIONTorsion NCS0.673415839356
ens_1d_3AAX-RAY DIFFRACTIONTorsion NCS0.642182070728
ens_1d_4AAX-RAY DIFFRACTIONTorsion NCS0.642376770862
ens_2d_2BBX-RAY DIFFRACTIONTorsion NCS0.656958653924
ens_2d_3BBX-RAY DIFFRACTIONTorsion NCS0.803387972259
ens_2d_4BBX-RAY DIFFRACTIONTorsion NCS0.726541092462
ens_3d_2CCX-RAY DIFFRACTIONTorsion NCS1.0136156588
ens_3d_3CCX-RAY DIFFRACTIONTorsion NCS1.92403498025
ens_3d_4CCX-RAY DIFFRACTIONTorsion NCS0.754525285737
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
2.3-2.330.31541230.26872576X-RAY DIFFRACTION100
2.33-2.360.34021420.27832542X-RAY DIFFRACTION99.96
2.36-2.40.28791170.26522578X-RAY DIFFRACTION100
2.4-2.430.36581280.27162578X-RAY DIFFRACTION99.96
2.43-2.470.32421470.27172523X-RAY DIFFRACTION100
2.47-2.510.32481390.26432583X-RAY DIFFRACTION99.85
2.51-2.550.31631190.25822537X-RAY DIFFRACTION100
2.55-2.60.31841310.25162580X-RAY DIFFRACTION100
2.6-2.650.34331300.25852561X-RAY DIFFRACTION99.96
2.65-2.70.29111390.24722546X-RAY DIFFRACTION100
2.7-2.760.28931320.24742577X-RAY DIFFRACTION99.96
2.76-2.830.30031300.24272581X-RAY DIFFRACTION99.96
2.83-2.90.30791560.23812565X-RAY DIFFRACTION100
2.9-2.980.27091400.22722559X-RAY DIFFRACTION99.85
2.98-3.060.29671220.22722596X-RAY DIFFRACTION99.93
3.06-3.160.25421170.22382607X-RAY DIFFRACTION99.96
3.16-3.280.24331690.21382546X-RAY DIFFRACTION99.85
3.28-3.410.25851540.22122592X-RAY DIFFRACTION99.96
3.41-3.560.2791490.21222605X-RAY DIFFRACTION99.89
3.56-3.750.27351260.21322615X-RAY DIFFRACTION99.93
3.75-3.980.21821480.18612613X-RAY DIFFRACTION99.93
3.98-4.290.2261360.17382622X-RAY DIFFRACTION99.89
4.29-4.720.20311450.17182651X-RAY DIFFRACTION99.89
4.72-5.410.22591450.18952668X-RAY DIFFRACTION99.79
5.41-6.810.2691440.23662716X-RAY DIFFRACTION99.9
6.81-48.490.18811630.19012867X-RAY DIFFRACTION98.57
Refinement TLS params.Method: refined / Origin x: 11.8709738076 Å / Origin y: -29.7391782204 Å / Origin z: -23.3660171821 Å
111213212223313233
T0.545442454986 Å20.00677856917295 Å2-0.0902781153041 Å2-0.353713347819 Å20.0185779179745 Å2--0.408942723431 Å2
L0.139844564986 °20.00611857023414 °2-0.0310140318809 °2-0.00323682578703 °20.0444187191732 °2---0.0327456119668 °2
S0.0236319576317 Å °0.0163279789877 Å °0.00631778301901 Å °-0.0237251127654 Å °-0.015737808812 Å °-0.00497788580353 Å °0.0160287770045 Å °0.0043398067101 Å °2.14274580204E-5 Å °
Refinement TLS groupSelection details: all

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more